Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older

• Ja Seo Koo,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliations Department of Pharmaceutical Medicine and Regulatory Sciences, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, South Korea, Department of Medical Affairs, Sanofi-aventis Korea Co., Ltd., Seoul, South Korea

  ⨯
• Seong Hwan Moon,

  Roles Methodology

  Affiliation Department of Orthopedic Surgery, College of Medicine, Yonsei University, Seoul, South Korea

  ⨯
• Hankil Lee,

  Roles Methodology

  Affiliations Institute of Health Services Research, Yonsei University, Seoul, South Korea, Graduate School of Public Health, Yonsei University, Seoul, South Korea

  https://orcid.org/0000-0002-7780-159X

  ⨯
• Sohee Park,

  Roles Conceptualization, Methodology

  Affiliation Graduate School of Public Health, Yonsei University, Seoul, South Korea

  ⨯
• Yun Mi Yu,

  Roles Methodology

  Affiliation College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea

  ⨯
• Hye-Young Kang

  Roles Conceptualization, Investigation, Methodology, Supervision, Writing – review & editing

  * E-mail: hykang2@yonsei.ac.kr

  Affiliation College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea

  https://orcid.org/0000-0003-3260-2623

  ⨯